Psychiatric and Somatic Markers of Anxiety
- 1 April 2000
- journal article
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 2 (2), 49-54
- https://doi.org/10.4088/pcc.v02n0204
Abstract
Anxiety disorders are widely prevalent but insufficiently recognized and inadequately treated in primary care practice. The annual costs of morbidity and mortality of these disorders approach $50 billion, substantially more than costs for schizophrenia or all affective disorders combined. Somatization of anxiety contributes to the challenges of making an accurate diagnosis and to the indirect costs associated with delaying appropriate treatment. Pharmacologic interventions give clinicians the necessary tools to treat anxiety safely and effectively. Former therapeutic choices were limited to benzodiazepines, buspirone, and older antidepressants, but newer anxiolytic agents have become available. The selective serotonin reuptake inhibitors and agents with dual reuptake inhibition, such as venlafaxine XR, are optimizing therapy and yielding less risk for serious adverse events, greater safety in long-term therapy, and opportunity for improved patient compliance. These newer antidepressants provide substantial efficacy in patients with comorbid anxiety and depression, commonly seen in the primary care setting.Keywords
This publication has 51 references indexed in Scilit:
- The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With AnxietyJournal of Clinical Psychopharmacology, 1998
- Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major DepressionThe Journal of Clinical Psychiatry, 1997
- Drug-Drug Interactions Involving Antidepressants: Focus on VenlafaxineJournal of Clinical Psychopharmacology, 1996
- Clinical Evaluation of VenlafaxineJournal of Clinical Psychopharmacology, 1996
- Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArchives of Family Medicine, 1994
- Prevalence of Medical Illness in Patients with Anxiety DisordersThe International Journal of Psychiatry in Medicine, 1994
- Distressed high utilizers of medical careGeneral Hospital Psychiatry, 1990
- Coexisting Major Depression and Obsessive-Compulsive Disorder Treated with VenlafaxineJournal of Clinical Psychopharmacology, 1990
- Common symptoms in ambulatory care: Incidence, evaluation, therapy, and outcomeAmerican Journal Of Medicine, 1989
- The Prognosis of Affective Disorders: the Differentiation of Anxiety States from Depressive IllnessesThe British Journal of Psychiatry, 1972